MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0245394

Медицинская библиотека · PloS one · 2021

Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.

Ruíz-Quiñonez Jesús Arturo, Guzmán-Priego Crystell Guadalupe, Nolasco-Rosales Germán Alberto, Tovilla-Zarate Carlos Alfonso, Flores-Barrientos Oscar Israel, Narváez-Osorio Víctor, Baeza-Flores Guadalupe Del Carmen, Gonzalez-Castro Thelma Beatriz, López-Brito Carlos Ramón, Denis-García Carlos Alberto, Pérez-García Agustín, Juárez-Rojop Isela Esther

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Due to the wide spread of SARS-CoV2 around the world, the risk of death in individuals with metabolic comorbidities has dangerously increased. Mexico has a high number of infected individuals and deaths by COVID-19 as well as an important burden of metabolic diseases; nevertheless, reports about features of Mexican individuals with COVID-19 are scarce. The aim of this study was to evaluate demographic features, clinical characteristics and the pharmacological treatment of individuals who died by COVID-19 in the south of Mexico.

METHODS

We performed an observational study including the information of 185 deceased individuals with confirmed diagnoses of COVID-19. Data were retrieved from medical records. Categorical data were expressed as proportions (%) and numerical data were expressed as mean ± standard deviation. Comorbidities and overlapping symptoms were plotted as Venn diagrams. Drug clusters were plotted as dendrograms.

RESULTS

The mean age was 59.53 years. There was a male predominance (60.1%). The mean hospital stay was 4.75 ± 4.43 days. The most frequent symptoms were dyspnea (88.77%), fever (71.42%) and dry cough (64.28%). Present comorbidities included diabetes (60.63%), hypertension (59.57%) and obesity (43.61%). The main drugs used for treating COVID-19 were azithromycin (60.6%), hydroxychloroquine (53.0%) and oseltamivir (27.3%).

CONCLUSIONS

Mexican individuals who died of COVID-19 had shorter hospital stays, higher frequency of shortness of breath, and higher prevalence of diabetes than individuals from other countries. Also, there was a high frequency of off-label use of drugs for their treatment.

Для цитирования: Ruíz-Quiñonez Jesús Arturo, Guzmán-Priego Crystell Guadalupe, Nolasco-Rosales Germán Alberto, Tovilla-Zarate Carlos Alfonso, Flores-Barrientos Oscar Israel, Narváez-Osorio Víctor, Baeza-Flores Guadalupe Del Carmen, Gonzalez-Castro Thelma Beatriz, López-Brito Carlos Ramón, Denis-García Carlos Alberto, Pérez-García Agustín, Juárez-Rojop Isela Esther. Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.. PloS one. 2021. DOI: 10.1371/journal.pone.0245394.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.